InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
OtherDisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by BeiGene, Ltd.. Insider active across 1 company, notably Leap Therapeutics, INC.. Aggregated, 2 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €12.4m. History available since 24 September 2021. The latest transaction was disclosed on 24 September 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
2,543,800 shares@ US$2.8550.0% of flowCommon StockSEC:0001651308-21-000197:0
Ideal exit: 21 Jun 2022 (T+270)
2,543,800 shares@ US$2.8550.0% of flowCommon StockSEC:0001651308-21-000197
Ideal exit: 21 Jun 2022 (T+270)
2 of 2 declarations
